Cargando…
Controversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy
ILC3s have been identified as crucial immune regulators that play a role in maintaining host homeostasis and modulating the antitumor response. Emerging evidence supports the idea that LTi cells play an important role in initiating lymphoid tissue development, while other ILC3s can promote host defe...
Autores principales: | Zhang, Yunshu, Feng, Xuefei, Chen, Juan, Liu, Jiahao, Wu, Jianmin, Tan, Hongpei, Mi, Ze, Rong, Pengfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090672/ https://www.ncbi.nlm.nih.gov/pubmed/37063879 http://dx.doi.org/10.3389/fimmu.2023.1134636 |
Ejemplares similares
-
Characterization of Rat ILCs Reveals ILC2 as the Dominant Intestinal Subset
por: Abidi, Ahmed, et al.
Publicado: (2020) -
Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology
por: Sunaga, Shogo, et al.
Publicado: (2022) -
PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer
por: Liu, Jiahao, et al.
Publicado: (2023) -
ILC2s—Trailblazers in the Host Response Against Intestinal Helminths
por: Bouchery, Tiffany, et al.
Publicado: (2019) -
Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes
por: Stojanović, Ivana, et al.
Publicado: (2021)